At the cell surface, AnxA2 heterotetramer complex provides binding site for both plasminogen and tissue type plasminogen activator (tPA) and converts plasminogen into plasmin [24,25,26,27], which plays an important role in invasion and metastasis of cancer. Here, ANXA2 is linked to cancer.